SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?

Cadrin-Tourigny, J; Krahn, AD; Saba, M (2023) Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used? Europace, 25 (5). euad132. ISSN 1532-2092 https://doi.org/10.1093/europace/euad132
SGUL Authors: Saba, Magdi Mohamed

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (471kB) | Preview
Item Type: Article
Additional Information: © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: Humans, Tachycardia, Defibrillators, Implantable, Humans, Tachycardia, Defibrillators, Implantable, 1103 Clinical Sciences, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Europace
ISSN: 1532-2092
Language: eng
Dates:
DateEvent
19 May 2023Published
22 May 2023Published Online
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
PubMed ID: 37213070
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115445
Publisher's version: https://doi.org/10.1093/europace/euad132

Actions (login required)

Edit Item Edit Item